Cited by 182Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchIntracerebral and Subarachnoid Hemorrhage Research

The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.

Amyloid Angiopathy and Variability in Amyloid β Deposition Is Determined by Mutation Position in Presenilin-1-Linked Alzheimer’s Disease

Open access

Mann, David M.A., Pickering-Brown, Stuart M., Takeuchi, Ayano, Iwatsubo, Takeshi·2001·The American Journal of Pathology

DOI 10.1016/s0002-9440(10)64688-3PMC PMC1891993

Open this paper in CoChat — free account Open PDF

Abstract

The presenilins (PSs) are components of large molecular complexes that contain beta-catenin and function as gamma-secretase. We report here a striking correlation between amyloid angiopathy and the location of mutation in PS-1 linked Alzheimer's disease. The amount of amyloid beta protein, Abeta(42(43)), but not Abeta(40,) deposited in the frontal cortex of the brain is increased in 54 cases of early-onset familial Alzheimer's disease, encompassing 25 mutations in the presenilin-1 (PS-1) gene, compared to sporadic Alzheimer's disease. The amount of Abeta(40) in PS-1 Alzheimer's disease varied according to the copy number of epsilon4 alleles of the Apolipoprotein E gene. Although the amounts of Abeta(40) and Abeta(42(43)) deposited did not correlate with the genetic location of the mutation in a strict linear sense, the histological profile did so vary. Cases with mutations between codon 1 and 200 showed, in frontal cortex, many diffuse plaques, few cored plaques, and mild or moderate amyloid angiopathy. Cases with mutations occurring after codon 200 also showed many diffuse plaques, but the number and size of cored plaques were increased (even when epsilon4 allele was not present) and these were often clustered around blood vessels severely affected by amyloid angiopathy. Similarly, diverging histological profiles, mainly according to the degree of amyloid angiopathy, were seen in the cerebellum. Mutations in the PS-1 gene may therefore alter the topology of the PS-1 protein so as to favor Abeta formation and deposition, generally, but also to facilitate amyloid angiopathy particularly in cases in which the mutation lies beyond codon 200. Finally we report that the amount of Abeta(42(43)) deposited in the brain correlated with the amount of this produced in culture by cells bearing the equivalent mutations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)64688-3

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity
Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,959
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Self-citation
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271

Show all 66 references

Research works printed but not linked: 2

Mann, 1992, The time course of pathological events concerned with plaque formation in Down's syndrome with particular reference to the involvement of microglial cells, Neurodegeneration, 1, 201
Perez-Tur, 1996, Identification of a mutation in Alzheimer's disease which destroys a splice acceptor site in the presenilin-1 gene, Neuroreport, 7, 204

Sorted by citations

Items 101–182 of 182

Pathological and clinical heterogeneity of presenilin 1 gene mutations
Menéndez‐González, M. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6503 · Cited by 29
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
Joseph‐Mathurin, N., Wang, G., Kantarci, K., Jack, C. R., McDade, E., Hassenstab, J. J., Blazey, T., Gordon, B. A., Su, Y., Chen, G., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011542 · Cited by 28
PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
Ghisays, V., Lopera, F. J., Goradia, D. D., Protas, H. D., Malek‐Ahmadi, M. H., Chen, Y., Devadas, V., Luo, J., Lee, W., Baena, A. Y., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102749 · Cited by 30
A novel mutation in the PSEN1 gene (L286P) associated with familial early‐onset dementia of Alzheimer type and lobar haematomas
Sánchez‐Valle, R., Lladó, A., Ezquerra, M., Rey, M. J., Rami, L., & Molinuevo, J. L. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01988.x · Cited by 29
A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations
Dowjat, W. K., Kuchna, I., Wısnıewskı, T., & Węgiel, J. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6105 · Cited by 27
Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies
Dileep, K. V., & Chandra, R. (2019) · Current Drug Targets · doi:10.2174/1389450120666190806153206 · Cited by 26
Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer’s disease
Willumsen, N., Poole, T., Nicholas, J. M., Fox, N. C., Ryan, N. S., & Lashley, T. (2021) · Brain Pathology · doi:10.1111/bpa.13009 · Cited by 25
Cerebral microbleeds in familial Alzheimer's disease
Ryan, N. S., de Bastos-Leite, A. J., Rohrer, J. D., Werring, D. J., Fox, N. C., Rossor, M. N., & Schott, J. M. (2011) · Brain · doi:10.1093/brain/awr126 · Cited by 26
Alzheimer’s Silent Partner: Cerebral Amyloid Angiopathy
Cupino, T. L., & Zabel, M. K. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0309-7 · Cited by 27
Presenilin-1 280Glu→Ala Mutation Alters C-Terminal APP Processing Yielding Longer Aβ Peptides: Implications for Alzheimer’s Disease
Vickle, G. D. V., Esh, C. L., Kokjohn, T. A., Patton, R., Kalback, W. M., Luehrs, D. C., Beach, T. G., Newell, A., Lopera, F. J., Ghetti, B. F., et al. (2008) · Molecular Medicine · doi:10.2119/2007-00094.vanvickle · Cited by 25
Studies on the first described Alzheimer's disease amyloid β mutant, the Dutch variant
Levy, E., Prelli, F., & Frangione, B. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s337 · Cited by 24
A 3’-UTR polymorphism in the oxidized LDL receptor 1 gene increases Aβ40 load as cerebral amyloid angiopathy in Alzheimer’s disease
Shi, J., Tian, J., Pritchard, A. L., Lendon, C. L., Lambert, J., Iwatsubo, T., & Mann, D. M. A. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1108-3 · Cited by 23
Self-citation
Genetic Animal Models of Cerebral Vasculopathies
Lee, J. H., Bacskai, B. J., & Ayata, C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00002-0 · Cited by 21
Increased Prevalence of Significant Recurrent Headache in Preclinical Familial Alzheimer’s Disease Mutation Carriers
Ringman, J. M., Romano, J. D., Medina, L. D., Rodríguez‐Agudelo, Y., Schaffer, B., Varpetian, A., Ortiz, F., Fitten, L. J., Cummings, J. L., & Baloh, R. W. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000121986 · Cited by 22
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy
Borroni, B., Pilotto, A., Bonvicini, C., Archetti, S., Alberici, A., Lupi, A., Gennarelli, M., & Padovani, A. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0714-1 · Cited by 22
Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred
Cochran, J. N., Acosta‐Uribe, J., Esposito, B. T., Madrigal, L., Aguillón, D., Giraldo, M. M., Taylor, J. W., Bradley, J., Fulton‐Howard, B., Andrews, S. J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13021 · Cited by 21
Spastic paraplegia preceding PSEN1 ‐related familial Alzheimer's disease
Chelban, V., Breza, M., Szaruga, M., Vandrovcová, J., Murphy, D. P., Lee, C., Alikhwan, S., Bourinaris, T., Vavougios, G. D., Ilyas, M., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12186 · Cited by 22
Familial Presenilin Mutations and Sporadic Alzheimer’s Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
Roher, A. E., Maarouf, C. L., & Kokjohn, T. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150757 · Cited by 22
Familial cases presenting very early onset autosomal dominant Alzheimer’s disease with I143T in presenilin-1 gene: implication for genotype–phenotype correlation
Arai, N., Kishino, A., Takahashi, Y., Morita, D., Nakamura, K., Yokoyama, T., Watanabe, T., Ida, M., Goto, J., & Tsuji, S. (2007) · Neurogenetics · doi:10.1007/s10048-007-0104-2 · Cited by 18
Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against β-amyloid (25–35)-induced apoptosis
Vaudry, D., Cottet‐Rousselle, C., Basille, M., Falluel‐Morel, A., Fournier, A., Vaudry, H., & Gonzalez, B. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.05.025 · Cited by 18
Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.
Roher, A. E., Maarouf, C. L., Malek‐Ahmadi, M. H., Wilson, J., Kokjohn, T. A., Daugs, I. D., Whiteside, C. M., Kalback, W. M., Macias, M. M. P., Jacobson, S. A., et al. (2013) · Europe PMC (PubMed Central) · Cited by 17
Génétique de la maladie d’Alzheimer : formes autosomiques dominantes
Guyant‐Maréchal, L., Campion, D., & Hannequin, D. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2008.10.019 · Cited by 20
A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain
Green, E., Thaker, U., McDonagh, A. M., Iwatsubo, T., Lambert, J., Chartier‐Harlin, M., Harris, J. M., Pickering-Brown, S. M., Lendon, C. L., & Mann, D. M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00190-8 · Cited by 17
Self-citation
Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
Joseph‐Mathurin, N., Feldman, R. L., Lu, R., Shirzadi, Z., Toomer, C., Clair, J. S., Ma, Y., McKay, N. S., Strain, J. F., Kilgore, C. B., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13729 · Cited by 15
Clinical, Genetic, and Neuroimaging Features of Early Onset Alzheimer Disease: The Challenges of Diagnosis and Treatment
Alberici, A., Benussi, A., Premi, E., Borroni, B., & Padovani, A. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141107151606 · Cited by 16
A Novel Pathogenic PSEN1 Mutation in a Family with Alzheimer's Disease: Phenotypical and Neuropathological Features
Gallo, M., Marcello, N., Curcio, S. A. M., Colao, R., Geracitano, S., Bernardi, L., Anfossi, M., Puccio, G., Frangipane, F., Clodomiro, A., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110185 · Cited by 16
I716F AβPP Mutation Associates with the Deposition of Oligomeric Pyroglutamate Amyloid-β and α-Synucleinopathy with Lewy Bodies
Berger–Sieczkowski, E., Milenković, I., Venkataramani, V., Giera, R., Ströbel, T., Höftberger, R., Liberski, P. P., Auff, E., Wirths, O., Bayer, T. A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141524 · Cited by 16
Relationship between neuronal loss and ‘inflammatory plaques’ in early onset Alzheimer's disease
Shepherd, C. E., Grace, E. M., Mann, D. M. A., & Halliday, G. M. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00816.x · Cited by 14
Self-citation
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome
Kasri, A., Camporesi, E., Gkanatsiou, E., Boluda, S., Brinkmalm, G., Stimmer, L., Ge, J., Hanrieder, J., Villain, N., Duyckaerts, C. J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02756-4 · Cited by 16
Cerebral Amyloid Angiopathy
Greenberg, S. M. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50039-0 · Cited by 13
Clinical Picture of a Patient With a Novel PSEN1 Mutation (L424V)
Robles, A., Sobrido, M. J., García-Murias, M., Prieto, J. M., Lema, I., Santos, D., & Páramo, M. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508324272 · Cited by 12
Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease
Millar, P. R., Gordon, B. A., Wisch, J. K., Schultz, S. A., Benzinger, T. L. S., Cruchaga, C., Hassenstab, J. J., Ibáñez, L., Karch, C. M. M., Llibre‐Guerra, J. J., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00688-3 · Cited by 12
PSEN1 Compound Heterozygous Mutations Associated with Cerebral Amyloid Angiopathy and Cognitive Decline Phenotype
Palmieri, I., Valente, M., Farina, L. M., Gana, S., Minafra, B., Zangaglia, R., Pansarasa, O., Sproviero, D., Costa, A. C., Pacchetti, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083870 · Cited by 9
Characterization of spastic paraplegia in a family with a novelPSEN1mutation
Ringman, J. M., Dorrani, N., Fernández, S. G., Signer, R. H., Martínez-Agosto, J. A., Lee, H., Douine, E. D., Qiao, Y., Shi, Y., D’Orazio, L. M., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad030 · Cited by 11
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease
Schultz, S. A., Shirzadi, Z., Schultz, A. P., Liu, L., Fitzpatrick, C. D., McDade, E., Barthélemy, N. R., Renton, A. E., Esposito, B. T., Joseph‐Mathurin, N., et al. (2023) · Aging Cell · doi:10.1111/acel.13871 · Cited by 10
Acute inhibition of AMPA receptors by perampanel reduces amyloid β‐protein levels by suppressing β‐cleavage of APP in Alzheimer's disease models
Ueda, S., Kuzuya, A., Kawata, M., Okawa, K., Honjo, C., Wada, T., Matsumoto, M., Goto, K., Miyamoto, M., Yonezawa, A., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202300837r · Cited by 10
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease
Iaccarino, L., Llibre‐Guerra, J. J., McDade, E., Edwards, L., Gordon, B. A., Benzinger, T. L. S., Hassenstab, J. J., Kramer, J. H., Li, Y., Miller, B. L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae159 · Cited by 11
The PSEN1 E280G mutation leads to increased amyloid-β43 production in induced pluripotent stem cell neurons and deposition in brain tissue
Willumsen, N., Arber, C., Lovejoy, C. E. J., Toombs, J., Alatza, A., Weston, P. S. J., Chávez‐Gutiérrez, L., Hardy, J., Zetterberg, H., Fox, N. C., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac321 · Cited by 10
Multiple Spontaneous Cerebral Microbleeds and Leukoencephalopathy in PSEN1-Associated Familial Alzheimer’s Disease: Mirror of Cerebral Amyloid Angiopathy?
Floris, G., Stefano, F. D., Cherchi, M. V., Costa, G., Marrosu, F., & Marrosu, M. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150165 · Cited by 10
Clinical Association of White Matter Hyperintensities Localization in a Mexican Family with Spastic Paraparesis Carrying the PSEN1 A431E Mutation
Santos-Mandujano, R., Ryan, N. S., Chávez‐Gutiérrez, L., Sánchez‐Torres, C., & Meraz‐Ríos, M. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190978 · Cited by 11
Three novel presenilin 1 mutations marking the wide spectrum of age at onset and clinical patterns in familial Alzheimer’s disease
Roeber, S., Müller‐Sarnowski, F., Kreß, J. A., Edbauer, D., Kuhlmann, T., Tüttelmann, F., Schindler, C., Winter, P., Arzberger, T., Müller, U., et al. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1450-0 · Cited by 10
Models of cerebral amyloid angiopathy-related intracerebral hemorrhage
Vargas-George, S. A., & Dave, K. R. (2022) · Brain Hemorrhages · doi:10.1016/j.hest.2022.05.001 · Cited by 10
PSEN1 Mutation Carriers Present Lower Cerebrospinal Fluid Amyoid-β42 Levels than Sporadic Early-Onset Alzheimer's Disease Patients but no Differences in Neuronal Injury Biomarkers
Balasa, M., Dídac Vidal-piñeiro, A., Lladó, A., Antonell, A., Bosch, B., Castellanos, F., Bargalló, N., Bartrés‐Faz, D., Molinuevo, J. L., & Sánchez‐Valle, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111949 · Cited by 9
The Usefulness of Biological and Neuroimaging Markers for the Diagnosis of Early‐Onset Alzheimer′s Disease
Padovani, A., Gilberti, N., & Borroni, B. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/296374 · Cited by 11
Difficult case of a rare form of familial Alzheimer’s disease with PSEN1 P117L mutation
Rocha, A. L., da Costa, A. G., Garrett, M. C., & Meireles, J. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-226664 · Cited by 8
Genetics and pathology of alpha-secretase site AβPP mutations in the understanding of Alzheimer's disease
Broeckhoven, C. V., & Kumar‐Singh, S. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s344 · Cited by 8
Genetics of primary intracerebral hemorrhage
Greenberg, S. M. (2002) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2002.129615 · Cited by 8
Early-onset familial Alzheimer’s disease related to presenilin 1 mutation resembling autosomal dominant spinocerebellar ataxia
Braga‐Neto, P., Pedroso, J. L., Alessi, H., de Souza, P. V. S., Bertolucci, P. H. F., & Barsottini, O. G. P. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6879-1 · Cited by 7
Neuropathology of Alzheimer’s disease in Down syndrome
Mann, D. M. A. (2018) · CRC Press eBooks · doi:10.1201/9781315376875-2 · Cited by 6
Self-citation
Presenilin Gene Mutation-associated Psychosis
Colijn, M. A., & Ismail, Z. (2024) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000599 · Cited by 5
A New Presenilin 1 (Psen1) Mutation (p.Cys263Trp) as a Cause of Both Early and Late-Onset Alzheimer’s Disease in a Large Italian Family
Tortelli, R., Seripa, D., Zecca, C., Dell’Abate, M. T., Bisceglia, P., Barulli, M. R., Blasi, R. D., & Logroscino, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126215 · Cited by 4
14 Amyloid Imaging and (What is “Normal”?) Aging
Klunk, W. E., & Mathis, C. A. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0014 · Cited by 5
Biobank-scale genetic characterization of Alzheimer’s disease and related dementias across diverse ancestries
Khani, M., Akçimen, F., Grant, S. M., Akerman, S. C., Lee, P. S., Faghri, F., Leonard, H. L., Kim, J. J., Makarious, M. B., Koretsky, M. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62108-y · Cited by 6
A Case of Early-Onset Alzheimer’s Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P)
Kim, H., Jang, J. H., Ham, H.-G., Choo, S. H., Park, J.-H., Kang, S. H., Hwangbo, S., Jang, H., Na, D. L., Seo, S. W., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210650 · Cited by 4
Familial cerebral amyloid disorders with prominent white matter involvement
Banerjee, G., Schott, J. M., & Ryan, N. S. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00010-7 · Cited by 3
Cerebral amyloid angiopathy
Greenberg, S. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511691836.005 · Cited by 3
Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation
Libard, S., Giedraitis, V., Kilander, L., Ingelsson, M., & Alafuzoff, I. I. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220655 · Cited by 3
Apolipoproteins in Different Amyloidoses
Sadowski, M., & Wısnıewskı, T. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_6 · Cited by 3
Novel presenilin 1 mutation (p.Thr-Pro116-117Ser-Thr) in a Spanish family with early-onset Alzheimer's disease
Garrote, J. A. B., Alonso, A., Blanco, J., Rojo, E., Orriols, J. J. T., Torres, M. Á., & Uribe, F. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.05.012 · Cited by 2
Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization
Altuna, M., Larumbe, R., Zelaya, M. V., Moreno, S., García-Solaesa, V., Mendióroz, M., Ramos, M. A., & Erro, M. E. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11125-8 · Cited by 2
Recording γ-secretase activity in living mouse brainsPreprint
Hou, S. S., Ikegawa, Y., Kwon, Y., Wieckiewicz, N., Houser, M. C., Lundin, B., Bacskai, B. J., Berezovska, O., & Maesako, M. (2024) · eLife · doi:10.7554/elife.96848 · Cited by 2
Biobank-scale characterization of Alzheimer’s disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestriesPreprint
Khani, M., Akçimen, F., Grant, S. M., Åkerman, S., Lee, P. S., Faghri, F., Leonard, H. L., Kim, J. J., Makarious, M. B., Koretsky, M. J., et al. (2024) · medRxiv · doi:10.1101/2024.11.03.24313587 · Cited by 2
The Genetics of Cerebral Microbleeds
Banerjee, G., Lynch, D. S., & Werring, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-41777-1_9 · Cited by 1
Role of cyclin-dependent kinase 5 in neurodegenerative disorders
Varma, K. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp12.1190 · Cited by 1
PSEN1 G417S mutation in a Chinese pedigree causing early-onset parkinsonism with cognitive impairment
Li, J., Qin, Y., Zhao, Y., Zeng, Q., Pan, H.-X., Liu, Z., Sun, Q., Xu, Q., Tan, J., Yan, X., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.016 · Cited by 1
Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae
Chen, K.-Y., Lin, Y., Cheng, C.-J., Huang, Y., Lin, S.-Y., Chen, C., & Chiu, C. (2024) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2024.11.001 · Cited by 1
News from the AAN Annual Meeting
Hurley, D. (2015) · Neurology Today · doi:10.1097/01.nt.0000466517.57967.8e · Cited by 1
Early Onset Familial Alzheimer's Disease: Is a Mutation Predictive of Pathology?
Galasko, D. R. (2005) · Research and perspectives in Alzheimer's disease · doi:10.1007/3-540-26522-8_5 · Cited by 1
Enfermedad de Alzheimer de inicio presenil esporádica: Caracterización clínico-biológica y diagnóstico precoz
Balasa, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Genetica delle demenze degenerative
Wallon, D., & Nicolas, G. (2015) · EMC - Neurologia · doi:10.1016/s1634-7072(15)73962-0
Génétique des formes autosomiques dominantes de maladie d’Alzheimer
Wallon, D., Campion, D., & Hannequin, D. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_9
Descripción genotípica y fenotípica de la enfermedad de Alzheimer tardía y familiar precoz: revisión
Carvajal-Castrillón, J., Jiménez, M. C. J., Restrepo, P. P., & Restrepo, F. J. L. (2015) · Medicina UPB · doi:10.18566/medupb.v34n2.a07
AmyloidDepositionBeginsintheStriatumofPresenilin-1 MutationCarriersfromTwoUnrelatedPedigrees
Lopresti, B., & Ikonomovic, M. D. (2007)
A Young Man with Memory and Walking Difficulties
Shin, M., Chamoun, M., Pascoal, T. A., Savard, M., Soucy, J., Guiot, M. C., Rosa‐Neto, P., & Gauthier, S. G. (2021) · Cambridge University Press eBooks · doi:10.1017/9781316941294.004
Cerebral amyloid angiopathy : new insights from transgenic mice
Herzig, M. C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003642738
Genetica della malattia di Alzheimer
Wallon, D., & Nicolas, G. (2022) · EMC - Neurologia · doi:10.1016/s1634-7072(22)47093-0
Recording γ-secretase activity in living mouse brains
Hou, S. S., Ikegawa, Y., Kwon, Y., Wieckiewicz, N., Houser, M. C., Lundin, B., Bacskai, B. J., Berezovska, O., & Maesako, M. (2024) · eLife · doi:10.7554/elife.96848.3
Recording γ-secretase activity in living mouse brainsPreprint
Hou, S. S., Ikegawa, Y., Kwon, Y., Houser, M. C., Lundin, B., Bacskai, B. J., Berezovska, O., & Maesako, M. (2024) · eLife · doi:10.7554/elife.96848.1
Recording γ-secretase activity in living mouse brainsPreprint
Hou, S. S., Ikegawa, Y., Kwon, Y., Wieckiewicz, N., Houser, M. C., Lundin, B., Bacskai, B. J., Berezovska, O., & Maesako, M. (2024) · eLife · doi:10.7554/elife.96848.2
Presenilin‐1 C779T Mutation Presenting With Rapidly Progressive Dementia and Medial Temporal Lobe MRI Changes
Blasi, M. T., Borioni, M. S., Nuti, F., Belvisi, D., Canevelli, M., Fabbrini, G., & Bruno, G. (2025) · Case Reports in Neurological Medicine · doi:10.1155/crnm/8251065
Additional file 1 of Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease
Millar, P. R., Gordon, B. A., Wisch, J. K., Schultz, S. A., Benzinger, T. L. S., Cruchaga, C., Hassenstab, J. J., Ibanez, L., Karch, C. M. M., Llibre‐Guerra, J. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26655946
Diversité clinico-radiologique des microangiopathies cérébrales : Etude phénotypique et génétique de l’angiopathie amyloïde cérébrale et des calcifications cérébrales primaires
Grangeon, L. (2022) · theses.fr (ABES) · doi:10.70675/44d51667ze0fez4d16z9334zc48e6ea9d190

Authors: Mann, D. M. A., Pickering-Brown, S. M., Takeuchi, A., & Iwatsubo, T.
Affiliations: University of Manchester (GB)
The University of Tokyo (JP)
Corresponding author: Mann, David M.A.
ORCID: Mann, David M.A.
Pickering-Brown, Stuart M.
Iwatsubo, Takeshi
Venue: The American Journal of Pathology
Publisher: Elsevier BV
Published: 2001-06
Volume: 158
Issue: 6
Pages: 2165-2175
ISSN: 0002-9440 (ISSN-L)
DOI: 10.1016/s0002-9440(10)64688-3
PMC: PMC1891993
OpenAlex: W1965252410
Cited by: 182
References: 66
Citations by year: 2025: 2 · 2024: 13 · 2023: 7 · 2022: 11 · 2021: 10 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 4 · 2016: 7 · 2015: 12 · 2014: 2 · 2013: 8 · 2012: 6
FWCI: 5.79
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: American Journal Of Pathology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords: amyloid angiopathy, presenilin 1, Alzheimer's disease, amyloid-beta deposition, amyloid-beta 42, Aβ40, familial Alzheimer's disease, mutation position, APOE ε4, cerebral amyloid angiopathy, diffuse plaques, frontal cortex, cerebellum, gamma-secretase, protein topology
MeSH terms: Adult, Alzheimer Disease, Animals, Apolipoproteins E, Cerebellum, Female, Frontal Lobe, Genotype, Humans, Male, Membrane Proteins, Middle Aged, Mutation, Peptide Fragments, Genetic Variation, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, COS Cells, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amyloid Angiopathy and Variability in Amyloid β Deposition Is Determined by Mutation Position in Presenilin-1-Linked Alzheimer’s Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks